State of Wisconsin Investment Board
TRDA icon

State of Wisconsin Investment Board’s Entrada Therapeutics TRDA Stock Holding History

State of Wisconsin Investment Board’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,023
Closed -$158K – 2573
2023
Q3 		$158K Buy
+10,023
New +$158K ﹤0.01% 2301
2023
Q1 		– Sell
-10,971
Closed -$148K – 2586
2022
Q4 		$148K Buy
+10,971
New +$192K ﹤0.01% 2294

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

State of Wisconsin Investment Board's TRDA Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of Entrada Therapeutics (TRDA) in Q4 2023, closing a stake of 10,023 shares — an estimated $158K sold.

State of Wisconsin Investment Board first reported a position in TRDA in Q4 2022 and held it in 2 quarters. The position peaked at $158K in Q3 2023. 62 funds tracked by Wall St. Rank hold TRDA as of Q4 2023.

  • State of Wisconsin Investment Board reported no remaining Entrada Therapeutics position as of Q4 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 10,023 Entrada Therapeutics shares in Q4 2023, an estimated $158K.
  • State of Wisconsin Investment Board first reported a position in Entrada Therapeutics in Q4 2022 and held it in 2 quarters.
  • State of Wisconsin Investment Board's Entrada Therapeutics position peaked at $158K in Q3 2023.
  • 62 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.